Skip to main content
. Author manuscript; available in PMC: 2016 May 25.
Published in final edited form as: ACS Chem Neurosci. 2015 Mar 24;6(4):535–541. doi: 10.1021/acschemneuro.5b00055

Figure 1.

Figure 1

Longitudinal PET studies in APP/PS1 transgenic mice of AD versus wild-type controls. (A) PET images (axial, coronal and sagittal) summed at 5-10 min post-injection of 10 month-old transgenic mice (left) versus WT controls (right); (B) Time-activity curves and (C) AUC measurement in whole brain between transgenic mice of AD versus WT controls in 3, 7 and 10 months.